Drug intelligence / Profile preview

zinc monoethylfumarate

Development stage: Unknown
Modality: Small Molecules

Overview

Zinc monoethylfumarate is a small molecule compound that consists of a zinc salt of monoethyl fumaric acid. It is classified as an experimental drug and does not currently have an established therapeutic use or approved indication. The chemical formula is C12H14O8Zn and it has been referenced under several synonyms including "zinc di(ethyl fumarate)" and "monoethyl fumarate zinc salt". There is no available information on its mechanism of action, clinical development status, or primary indications in humans[8].

Other names: zinc monoethylfumarateethyl fumarate zincethyl hydrogenfumarate-zincmonoethyl fumarate zinc saltzinc di(ethyl fumarate)zinc ethyl fumarate

Targets

KEAP1 (Kelch-like ECH-associated protein 1)

Beyond the preview

Go deeper on zinc monoethylfumarate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on zinc monoethylfumarate.

Explore the full profile